Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/533573 stock hub

BOM/533573 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/533573is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

154.7B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/533573

In the news

Latest news · BOM/533573

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.4

P25 n/aP50 n/aP75 n/a

Trailing P/E24.6

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC10.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/533573 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

INR

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	16,571
Employees Change	1,713%
Employees Change Percent	11.53
Enterprise value	INR 168.1B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 154.7B
Price	INR 785
Price currency	INR
Rev Per Employee	4,385,251.34x
Sic	2834
Symbol	bom/533573
Website	https://alembicpharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.07%
EV Earnings	26.73x
EV/EBIT	19.5x
EV/EBITDA	14.68x
EV/Sales	2.31x
Forward P/E	19.41x
P/B ratio	2.91x
P/E ratio	24.6x
P/S ratio	2.13x
PE Ratio10 Y	25.05x
PE Ratio3 Y	29.68x
PE Ratio5 Y	30.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.88%
EBITDA Margin	15.51%
Gross margin	71.51%
Gross Profit	INR 52B
Gross Profit Growth	10.65%
Gross Profit Growth Q	7.51%
Gross Profit Growth3 Y	9.59%
Gross Profit Growth5 Y	5.05%
Net Income	INR 6.3B
Net Income Growth	4.01%
Net Income Growth Q	-3.94%
Net Income Growth3 Y	43.85%
Net Income Growth5 Y	-11.4%
Pretax Margin	10.56%
Profit Margin	8.66%
Profit Per Employee	INR 379,555
Roa5y	7.03
Roe5y	14.01
ROIC	10.58
Roic5y	12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.01%
Cagr1y	-11.47%
Cagr3y	13.56%
Cagr5y	-2.33%
Div CAGR10	10.65%
Div CAGR3	11.2%
Div CAGR5	-4.71%
EPS Growth	4.44
EPS Growth Q	-3.57
EPS Growth3 Y	43.94
EPS Growth5 Y	-11.8
Revenue Growth	13.2x
Revenue Growth Q	10.84x
Revenue Growth3 Y	8.67x
Revenue Growth5 Y	6.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1.4B
Debt	INR 14.9B
Debt EBITDA	INR 1.3
Debt Equity	INR 0.28
Equity	INR 53.2B
Interest Coverage	9.03
Net Cash	INR -13.5B
Net Cash By Market Cap	INR -8.7
Net Debt EBITDA	INR 1.19
Net Debt Equity	INR 0.25
Tangible Book Value	INR 51B
Tangible Book Value Per Share	INR 259

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.41%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 11
Dividend Years	14
Dividend Yield	1.44%
Ex Div Date	2025-07-29
Last Dividend	INR 11
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	48.2%
1Y total return	-11.47%
200-day SMA	853.4
3Y total return	46.46%
50-day SMA	721.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-11.12%
All Time High	1,296.2
All Time High Change	-39.41%
All Time High Date	2024-10-09
All Time Low	34
All Time Low Change	2,210%
All Time Low Date	2012-01-02
ATR	23.27
Ch YTD	-7.4
High	800.6
High52	1,107.8
High52 Date	2025-06-30
High52ch	-29.1%
Low	776.8
Low52	635.3
Low52 Date	2026-03-23
Low52ch	23.63%
Ma50ch	8.9%
Price vs 200-day SMA	-7.97%
RSI	62.38
RSI Monthly	45.73
RSI Weekly	48.59
Sharpe ratio	-0.31x
Sortino ratio	-0.29
Total Return	1.85%
Tr YTD	-7.4
Tr1m	13.79%
Tr1w	2.68%
Tr3m	-1.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 8.6B
Operating Income Growth	20.39
Operating Income Growth Q	12.19
Operating Income Growth3 Y	37.54
Operating Income Growth5 Y	-9.37
Operating margin	11.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	57,860,636%
Shares Insiders	5.53%
Shares Institutions	17.21%
Shares Qo Q	0.1%
Shares Yo Y	-0.41%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	6,930.5x
Bv Per Share	270.7
Ch10y	32.29
Ch1m	13.79
Ch1w	2.68
Ch1y	-12.44
Ch3m	-1.71
Ch3y	41.67
Ch5y	-16.56
Ch6m	-14.78
Change	1.04%
Change From Open	0.26
Close	777.4
Days Gap	0.78
Depreciation Amortization	2,637,875,000
Dollar Volume	11,499,826.8
Earnings Date	2026-05-15
EBIT	INR 8.6B
EBITDA	INR 11.3B
EPS	INR 32.07
F Score	1
Fiscal Year End	March
Founded	1,907
Graham Number	440.33439
Graham Upside	-43.94
Income Tax	INR 1.4B
Is Primary Listing	0
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Lynch Fair Value	INR 160
Lynch Upside	-79.67
Ma150	815.3
Ma150ch	-3.66%
Ma20	758.1
Ma20ch	3.6%
Next Earnings Date	2026-05-15
Open	783.4
Payment Date	2025-09-04
Position In Range	36.34
Price Date	2026-05-08
Price EBITDA	INR 13.72
Ptbv Ratio	3.04
Relative Volume	2.11x
Revenue	72,668,000,000x
Tax By Revenue	1.94x
Tax Rate	18.42%
Tr6m	-14.78%
Volume	14,642

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BOM/533573 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$11.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-4.7%

0 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2025-07-29

Performance

BOM/533573 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/533573?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.2%

Share of float held by funds and institutions

Insider ownership

+5.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.4%

Negative means the company is buying back shares.

Technical

BOM/533573 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.4

Neutral momentum band

Price vs 200-day MA

-8.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/533573

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/533573 stock rating?

bom/533573 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/533573 analysis?

The full report lives at /stocks/bom/533573/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/533573?

The latest report frames bom/533573 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/533573 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.